Inhibitors of gangliosides metabolism for the treatment of motor neuron diseases
申请人:ICM (INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE)
公开号:US11065238B2
公开(公告)日:2021-07-20
The present invention relates to inhibitors of gangliosides metabolism for treating motor neuron diseases, in particular hereditary spastic paraplegias.
本发明涉及用于治疗运动神经元疾病,特别是遗传性痉挛性截瘫的神经节苷脂代谢抑制剂。
INHIBITORS OF GANGLIOSIDES METABOLISM FOR THE TREATMENT OF MOTOR NEURON DISEASES
申请人:ICM (INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE)
公开号:US20190350913A1
公开(公告)日:2019-11-21
The present invention relates to inhibitors of gangliosides metabolism for treating motor neuron diseases, in particular hereditary spastic paraplegias.
[EN] GLUCOSYLCERAMIDE SYNTHASE INHIBITORS<br/>[FR] INHIBITEURS DE LA GLUCOSYLCÉRAMIDE SYNTHASE